Headache

Featured Article

Managing Comorbid Migraine and Mood Disorders: A Synergistic Approach

Managing Comorbid Migraine and Mood Disorders: A Synergistic Approach

People with migraines and comorbid mood disorders often need treatments that address both conditions, as well as management of sleep, stress, and lifestyle issues.

Latest

High Frequency of Headaches Following Dialysis Associated With BUN and Blood Pressure

High Frequency of Headaches Following Dialysis Associated With BUN and Blood Pressure

Compared with patients not reporting headache, patients with HRH had significantly greater differences in pre- and post-BUN values.

Erenumab Superior to Placebo for Reducing Migraine Disability, Improving HRQoL

Erenumab Superior to Placebo for Reducing Migraine Disability, Improving HRQoL

A significantly lower percentage of patients receiving a 70-mg or 140-mg dose of erenumab had severe disability during treatment compared with placebo.

Migraine Prevention Treatment Emgality Gets FDA Approval

Migraine Prevention Treatment Emgality Gets FDA Approval

The approval was based on data from 3 randomized, double-blind, placebo-controlled trials (EVOLVE-1, EVOLVE-2, REGAIN) in patients with either episodic or chronic migraine.

Fremanezumab May Have Long-Term Efficacy as a Prophylactic for Chronic Migraine

Fremanezumab May Have Long-Term Efficacy as a Prophylactic for Chronic Migraine

Fremanezumab treatment may be efficacious in reducing the number of monthly headache days in the long-term in people with chronic migraine.

Ajovy Injection Approved for Migraine Prevention in Adults

Ajovy Injection Approved for Migraine Prevention in Adults

The primary efficacy endpoint was the mean change from baseline in the monthly average number of headache days of at least moderate severity during the 3-month treatment period.

Few With Acute Migraine Take Triptans, Many Discontinue the Drug

Few With Acute Migraine Take Triptans, Many Discontinue the Drug

Few patients were found to take triptan medications to treat acute migraine, and a majority of those who had, discontinued the treatment due to side effects.

Lasmiditan May Be Effective as Acute Migraine Treatment

Lasmiditan May Be Effective as Acute Migraine Treatment

Lasmiditan was found to be more effective compared with placebo in eliminating pain and other symptoms associated with headache in individuals with migraine.

Use and Overuse of Acute Medications Common Among Migraineurs

Use and Overuse of Acute Medications Common Among Migraineurs

Investigator analyzed the number of scripts and days of therapy in patients with migraine to determine use and frequency of overuse.

Fremanezumab May Be Efficacious for Comorbid Chronic Migraine and Depression

Fremanezumab May Be Efficacious for Comorbid Chronic Migraine and Depression

Fremanezumab may be efficacious for the prophylaxis of chronic migraine in individuals with comorbid migraine and moderate/moderate to severe depression.

Lower Dose DFN-11 for Episodic Migraine Associated With Fewer Side Effects

Lower Dose DFN-11 for Episodic Migraine Associated With Fewer Side Effects

DFN-11, a 3 mg subcutaneous sumatriptan autoinjector, may provide an alternative to SC sumatriptan 6 mg for individuals with episodic migraine.

Sign Up for Free e-newsletters



CME Focus